2020 ASCO Virtual Direct™ Highlights

 

2020 ASCO Virtual Direct™ Highlights
Avatar

2020 ASCO Update on Bladder Cancer: Does Adjuvant Atezolizumab Improve DFS in Patients With High-risk MIUC?

By 2020 ASCO Virtual Direct™ Highlights FEATURING Manojkumar Bupathi
By 2020 ASCO Virtual Direct™ Highlights FEATURING Manojkumar Bupathi
70 views
August 4, 2020
0 Comments
Login to view comments. Click here to Login

Featured Video

15:14
Icahn School of Medicine at Mount Sinai

Safety Profile of Ruxolitinib in Patients With MF

Feat. D. Tremblay

Featured Video

13:04
Winship Cancer Institute - Emory University

Treatment-Related Quality of Life in MF

Feat. A. Hunter
GU
08:56
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Highlights on Advanced Prostate Cancer: Is Relugolix Bette…

Feat. B. Somer
13:12
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Updates on PSMA in Prostate Cancer: How Useful Is 18F-DCFP…

Feat. B. Somer
11:01
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Updates on CRPC: Apalutamide vs. Enzalutamide vs. Daroluta…

Feat. B. Somer
11:09
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on Advanced Bladder Cancer: Can We Consider Aveluma…

Feat. M. Bupathi
12:28
2020 ASCO Virtual Direct™ Highlights

2020 ASCO mRCC Highlights: Does the Updated KEYNOTE-426 Analysis Sup…

Feat. M. Bupathi
08:36
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on Bladder Cancer: Does Adjuvant Atezolizumab Impro…

Feat. M. Bupathi